SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gum Tech (GUMM)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DanZ who wrote (100)1/30/1999 4:20:00 PM
From: Bengalus  Read Replies (1) of 133
 
Dan,

I haven't shorted the stock yet because I haven't been able to borrow it. And I may wait a while to see if you folks can hype it more. But given the hundreds of products that never succeed despite multiple positive clinical trial results published in peer-reviewed journals, it's pretty unlikely GUMM has stumbled onto the holy grail. So yes, I would be playing the odds, but the odds look excellent.

If I wanted to speculate on a cure for the common cold, I would buy Quigley. The company has a brand, a product, substantial sales, incredible profit margins, lots of cash. GUMM has nada.

For people doing back of the envelope math on GUMM's potential sales and profits, Quigley makes for the most logical comparison. It ought to provide investors with some perspective on these pie-in-the-sky fantasies.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News